Ypsomed Hldg N
YPSN
CHF
STOCK MARKET:
SWX
Closed
 
...
Large gap with delayed quotes
Last quote
05/29/2026 - 17:31:09
Bid
05/29/2026 - 18:40:00
Bid
Volume
Ask
05/29/2026 - 18:40:00
Ask
Volume
350.40
+4.80 ( +1.39% )
350.00
25
353.40
60
More information
Analysis by TheScreener
29.05.2026
Evaluation Neutral  
Interest Weak  
Sensibility Middle  
Analysis date: 29.05.2026
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 21.04.2026.
Interest
  Weak
Two stars since 22.05.2026.
Earnings Rev Trend
  -0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 19.05.2026 at a price of 304.40.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 12.05.2026.
4wk Rel Perf
  22.12%
 
The four-week dividend-adjusted overperformance versus STOXX600 is 22.12%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 21.04.2026.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.40%.
Mkt Cap in $bn
  6.10
With a market capitalization between $2 & $8bn, YPSOMED HOLDING AG is considered a mid-cap stock.
G/PE Ratio
  0.79
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  19.42
The estimated PE is for the year 2029.
LT Growth
  14.05%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
  12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
  1.34%
The twelve month estimated dividend yield represents 26.03% of earnings forecasts.
Beta
  101
For 1% of index variation, the stock varies on average by 1.01%.
Correlation
  0.39
Stock movements are strongly independent of index variations.
Value at Risk
  84.10
The value at risk is estimated at CHF 84.10. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  16.03.2005